Altarea Valuation
Is ALTA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ALTA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ALTA (€97.6) is trading above our estimate of fair value (€51.1)
Significantly Below Fair Value: ALTA is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ALTA?
Key metric: As ALTA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is ALTA's PS Ratio? | |
|---|---|
| PS Ratio | 0.8x |
| Sales | €2.53b |
| Market Cap | €2.14b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.3x |
| Enterprise Value/EBITDA | -70x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ALTA's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.9x | ||
MLURC Urbanizadora Constructora Levantina SOCIMI | 38.2x | n/a | €192.9m |
ICAD Icade | 1.1x | 4.3% | €1.7b |
CARM Carmila | 4.9x | -2.0% | €2.3b |
ARG Argan | 7.3x | 0.7% | €1.7b |
ALTA Altarea | 0.8x | 2.1% | €2.1b |
Price-To-Sales vs Peers: ALTA is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (12.9x).
Price to Sales Ratio vs Industry
How does ALTA's PS Ratio compare vs other companies in the European Residential REITs Industry?
Price-To-Sales vs Industry: ALTA is good value based on its Price-To-Sales Ratio (0.8x) compared to the European Residential REITs industry average (8.9x).
Price to Sales Ratio vs Fair Ratio
What is ALTA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.8x |
| Fair PS Ratio | 1.4x |
Price-To-Sales vs Fair Ratio: ALTA is good value based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (1.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Healthcare Activos Yield SOCIMI
€245.6m
Operates as a real estate investment vehicle that focuses on the healthcare sector in Europe.
MLHAY
€1.41
7D
0%
1Y
4.4%
Paref
€61.4m
Owns and manages business real estate located primarily in the Paris region.
PAR
€40.70
7D
1.8%
1Y
-14.9%
Faifey Invest Socimi
€98.7m
Invests in real estate assets in Spain.
MLECE
€19.50
7D
0%
1Y
20.4%